vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT
· Real-Time Price · USD
15.46
1.43 (10.19%)
At close: Aug 15, 2025, 3:58 PM
15.73
1.75%
After-hours: Aug 15, 2025, 04:10 PM EDT
vTv Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -7.38M | -6.22M | -4.44M | -5.84M | -6.41M | -4.87M | -3.48M | -8.54M | -7.21M | -5.77M | -6.09M | -5.47M | -4.09M | -9.42M | -9.48M | -1.47M | -841K | -5.94M |
Depreciation & Amortization | 3K | 9K | 22K | 22K | 23K | 22K | 23K | 22K | 23K | 22K | 23K | 24K | 22K | 23K | 22K | 22K | 22K | 23K |
Stock-Based Compensation | 930K | 813K | 825K | 853K | 859K | 220K | 403K | 433K | 399K | 343K | 291K | 338K | 167K | 476K | 994K | 474K | 452K | 436K |
Other Working Capital | n/a | 499K | -173K | 1.15M | -1.68M | 461K | 729K | -548K | 522K | -1.21M | 832.86K | -3.52M | 3.03M | 732K | -9K | -1.45M | 195K | -987K |
Other Non-Cash Items | 1.35M | -791K | -1.24M | -162K | -193K | -783K | -1.26M | 3.3M | 3.15M | -1.65M | -284K | -220K | 64K | 2.74M | 4.69M | -623K | -4.06M | -53K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 108K | n/a | -3.79M | n/a | n/a | n/a | n/a | n/a | -6.33M | 378K | 233K | 1.7M |
Change in Working Capital | n/a | 499K | 7K | -1.29M | -1.01M | -1.93M | 1.29M | -48K | 1.26M | 1.9M | -820K | -3.5M | 4.54M | 5.16M | 3.68M | -2.38M | 197K | -1.46M |
Operating Cash Flow | -5.09M | -5.69M | -4.83M | -6.42M | -6.73M | -7.33M | -2.91M | -4.83M | -6.17M | -5.17M | -6.88M | -8.83M | 706K | -1.02M | -6.42M | -3.59M | -4M | -5.3M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 20.98K | n/a | -21K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 4.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 4.4M | n/a | n/a | n/a | 20.98K | n/a | -21K | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | 191K | n/a | n/a | -191K | -12.31M | -93K | n/a | 11.81M | -333K | 557K | n/a | -256K | -380K | 636K | n/a | -84K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -42K | n/a | 50.14M | n/a | n/a | n/a | n/a | -11.46M | n/a | n/a | 4M | 5.75M | n/a | n/a | n/a | -47K | n/a | 47K |
Financial Cash Flow | -42K | n/a | n/a | 2.46M | n/a | 50.14M | -282K | 473K | n/a | 11.81M | 3.67M | 6.3M | 5.04M | -256K | 266K | 12.32M | 6.38M | 8M |
Net Cash Flow | -5.14M | -5.69M | -4.83M | -3.96M | -6.73M | 42.81M | 1.21M | -4.36M | -6.17M | 6.64M | -3.21M | -2.52M | 5.72M | -1.28M | -6.15M | 8.73M | 2.39M | 2.7M |
Free Cash Flow | -5.09M | -5.69M | -4.83M | -6.42M | -6.73M | -7.33M | -2.91M | -4.83M | -6.17M | -5.17M | -6.86M | -8.83M | 685K | -1.02M | -6.42M | -3.59M | -4M | -5.3M |